McIvor Katherine, Moore Perry
a Department of Clinical Neuropsychology , The Walton Centre NHS Foundation Trust , Liverpool , UK.
b School of Medicine , University of Liverpool , Liverpool , UK.
Clin Neuropsychol. 2017 Jan;31(1):289-300. doi: 10.1080/13854046.2016.1245358. Epub 2016 Oct 20.
Anti N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune disorder that was only fully discovered recently and neuropsychological outcome data remains sparse. We present the case of BA, a 19-year-old male, which illustrates the cognitive outcome in an untreated case over a time period of over 2½ years.
We conducted three cognitive assessments, including tests of memory and executive functioning, over this time period and considered the evidence for reliable change in memory function using the Wechsler Advanced Clinical Solutions (ACS) serial assessment package.
Our findings revealed mild memory problems 6 months post-discharge with, at best, static and potentially declining memory functioning at follow-up assessment 12 months post-discharge. However, the results of testing at 30 months post-discharge revealed significant improvements in immediate and delayed memory index performances.
Our report of a case of anti-NMDAR encephalitis provides evidence for spontaneous improvements in memory functioning occurring more than 2 years after initial assessment and also demonstrates both the utility and potential limitations of the ACS serial assessment software when used in a relatively typical clinical assessment situation.
抗N-甲基-D-天冬氨酸受体(抗NMDAR)脑炎是一种自身免疫性疾病,直到最近才被充分发现,且神经心理学预后数据仍然稀少。我们报告了19岁男性BA的病例,该病例展示了一名未经治疗的患者在超过两年半时间内的认知预后情况。
在此期间,我们进行了三次认知评估,包括记忆和执行功能测试,并使用韦氏高级临床解决方案(ACS)系列评估软件包来评估记忆功能可靠变化的证据。
我们的研究结果显示,出院6个月后存在轻度记忆问题,在出院后12个月的随访评估中,记忆功能充其量处于稳定状态且可能有所下降。然而,出院后30个月的测试结果显示,即时和延迟记忆指数表现有显著改善。
我们对抗NMDAR脑炎病例的报告为初始评估两年多后记忆功能的自发改善提供了证据,同时也展示了ACS系列评估软件在相对典型的临床评估情况下的实用性和潜在局限性。